HUM-MOLGEN events: IBC's Accelerating Drug Discovery to Development via Cutting Edge ADMET

HUM-MOLGEN -> Events -> Meetings and Conferences

IBC's Accelerating Drug Discovery to Development via Cutting Edge ADMET

May 19, 2003

-, Doubletree Guest Suites * Boston, MA
September 15-16, 2003

At IBC’s 6th Annual Accelerating Drug Discovery to Development via Cutting Edge ADMET, you will hear industry experts for present the newest strategies, methodologies and technologies that are making it possible to optimize the ADME/Tox/safety characteristics in new drug compounds. Industry leaders offer insight on what technology advances they need, what’s missing and how the technologies are transforming R&D productivity and early attrition through state-of-the-art ADMET. Register early to ensure your place!

Organized by:

IBC Life Sciences

Invited Speakers:

Keynote Presentation:
Christopher A. Lipinski, Ph.D., Pfizer Global R&D Groton Laboratories

Deadline for Abstracts:

Registration:

Online: www.LifeSciencesInfo.com/ADMET Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 E-mail: reg@ibcusa.com

E-mail:

reg@ibcusa.com

Posted by:

James G. Prudhomme

Host: